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Euphoria is an affective state and a form of pleasure that goes back to
biblical times. It makes a person experience intense forms of well-being,
happiness, and often ecstasy. It has often been suggested that euphoria
induced by alcohol and other drugs/compounds (e.g., psychoactive
drugs, designer drugs, stimulants, nicotine, gamma-hydroxybutyric
acid, ketamine, etc.) occurs via a stimulation of all hedonic hotspots
within the brain’s reward system [1]. Interestingly, asphyxiation
initially produces an intense feeling of euphoria, often leading people
to intentionally induce asphyxiation and erotic sensations (i.e., brief
episodes of hypoxia such as choking).
More than 35 years ago, three of us, using a TV-imageintensification recording system, at magnifications up to 3,200 times
(pioneered by our lab) [2] and using in-vivo examination of the living
brain microcirculation in different anesthetized rodents (i.e., rats, mice,
guinea-pigs) reported that very small amounts of alcohol (equivalent to
one-two drinks) reversibly constricted arterioles (20-40 µm in diameter)
and muscular venules (40-75 um in diameter) [3]. These initial findings
suggested to us that the amount of alcohol in only two cocktail drinks
may be enough to curtail blood flow in the brain to the point that
some key neurons, glial cells, and astrocytes do not get enough oxygen
to function properly. We suggested, like that seen in pilots at high
altitude (> 15,000 feet) in non-pressurized cabins, in World War II,
who experienced a euphoric sense of well-being, drinking of alcohol
and the taking of diverse psychoactive/designer drugs can reversibly
induce vasoconstriction of the cerebral microscopic blood vessels, thus
producing oxygen-lack and temporary light-headedness and euphoria.
The neurons, glial cells, and astrocytes in select areas of the brain would
thus be starved for oxygen like unprotected pilots at high-altitude. Until
the advent of pressurized cabins, many pilots in World War II became
very euphoric, blacked out, lost control of their aircraft and perished.
Using isolated arteries from brains of anesthetized, sacrificed rats,
guinea-pigs, dogs, and subhuman primates, bathed in physiological salt
solutions, our laboratories found that various alcohols (i.e., ethanol,
methanol, and butanol) caused concentration-dependent contractions,
similar to the in-vivo studies on the living brains of rodents [3-15]. The
greater the dose of alcohol, the greater the vasoconstrictor-contractile
effects and the longer the contractions remain unabated [3-16]. Such
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effects clearly could be the cause of the sequelae of effects noted
with increased consumption of cocktails, beers, and various liquors,
i.e., the failure to be able to walk a straight line, the failure to drive
a vehicle safely, unconsciousness, coma and in rare cases strokes and
death [3,7-16]. Drinking of alcohol thus can be, and often is, lethal.
In fact, drinking of alcohol is the most abused type of drug/behavior
[1,17,18]. Other experiments from our group have shown that
hallucinogenic drugs such as LSD, phencyclidine (PCP, “angel dust”),
pysilocybin, mescaline, heroin, pyote, cocaine, excitatory amino acids
and derivatves (i.e., designer drugs) also promote vasoconstriction of
brain blood vessels [19-27]. The concentrations of PCP, mescaline,
LSD and cocaine that produced near maximum and intense euphoria,
often leading to death, were similar to the concentrations in the blood
and brains of humans who had died from overdoses of PCP, LSD, and
mescaline.
Using rats addicted to ethanol, we found that the in-situ cerebral
micro vessels as well as cerebral and peripheral arteries (removed
from the addicted animals) gradually , with the passage of time (and
increased blood alcohol levels), became tolerant to the alcohol [8,10,14,
unpublished findings]. In other words, it takes higher and higher
concentrations of alcohol to induce microvascular contractions, which
would thus produce a need for increased blood alcohol levels in order
to induce euphoric states, exactly as occurs in humans with increased
drinking. Breathing is controlled by the brain. Cutting off the blood
supply to the neurons, etc., that regulate breathing may produce
euphoria at very low concentrations of alcohol and hallucinations at
higher blood levels of alcohol.
What, however, is the exact mechanism(s) which induce euphoria
and hallucinations via a reduced cerebral vascular blood and oxygen
supply? Until now, speculation resided in a release of endorphins,
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gamma-hydroxybutryic acid-like substances, and a variety of putative
neurotransmitters [14,15,17,18]. However, none of these substances
and multiple transmitters (e.g., norepinephrine, dopamine, serotonin,
histamine, prostanoids, neuropeptides, glutamic acid, etc.) that we [1317, 28-31; unpublished studies on microvasculatures of rodent brains]
and others have tested [32] produce ischemic actions in the brain
microvasculature at blood levels found to be released with imbibing
of alcohol.
We now believe that a rapid, reversible release of free magnesium
ions ([Mg2+]) coupled to the release of ceramides and platelet-activating
factor(PAF) may account for most of the alcohol-induced euphoria.
Below, we discuss why this hypothesis looks tenable to us.
Many drugs including alcohol are now known to induce reversible
Mg2+ deficiency in organs, tissues, and cells in both animals and
humans. Flink and his co-workers in 1954 were the first to demonstrate
severe hypomagnesemia in alcoholic patients [33]. Over the succeeding
years these findings have been confirmed and extended by others [34].
In fact, infusions of magnesium sulfate have been standard treatment
of delirium tremens for a good number of years. Approximately 25
years ago, our group, for the first time, employing 31P-nuclear magnetic
resonance (31P-NMR) spectroscopy and optical spectroscopy on the
living intact brains of animals as well as utilization of digital-imaging
microscopy on a variety of isolated cerebral vascular smooth muscle
(VSM) cells, and use of highly- specific Mg2+ electrodes, found that
alcohol rapidly (i.e., within seconds) lowered intracellular free Mg2+
[12-15]. Using these techniques coupled with 31P- NMR spectroscopy
and measurements of lumen sizes (and microvascular blood flows)
in the intact brains of rodents, as well as use of a variety of isolated
cerebral arteries, we found profound concentration-dependent
vasoconstriction of the blood vessels and increasing ischemia, as
evidenced by rising cellular concentrations of inorganic phosphate
coupled to acidic intracellular pH, rises in deoxyhemoglobin , reduced
mitochondrial levels of cytochrome oxidase and considerable loss of
high-energy phosphate compounds [12-15 ].
Mg2+ is a co-factor for more than 500 enzymes, and is the second
most abundant intracellular cation after potassium [35]. It is vital in
numerous physiological, cellular and biochemical reactions including
carbohydrate, lipid, protein, DNA and RNA metabolism, among other
pathways [35,36]. Several epidemiologic studies in North America and
Europe have shown that people consuming Western-type diets are low
in Mg content (i.e., 30-65% of the RDA for Mg) [37-40]; most such
diets show that 60-80% of Americans are consuming 185-235 mg/day
of Mg [39,40]. In 1900, in contrast, most Americans were consuming
450-550 mg/day of Mg [41]. Mg deficiency amongst the American and
European populations could help to explain why, often, very low levels
of alcohol can produce euphoric and hallucinatory events. This might
also help to explain why many individuals do not experience euphoria
or hallucinations after drinking more than two standard cocktail drinks
containing alcohol, as their blood and tissue levels of Mg2+ are most
likely elevated due to diets containing elevated levels of Mg.
But, does low Mg2+-induced cerebral vasoconstriction and
temporary ischemia in key areas of the brain account, in large measure
for the euphoria, and if so, what is the molecular mechanism(s)?
Approximately 40 years ago, two of us demonstrated using isolated
cerebral, coronary, and peripheral arteries that a lowering of
extracellular Mg2+([Mg2+]0) levels resulted in a rapid rise in intracellular
free calcium ions just prior to contractile events [42-44]. More recently,
our group found that lowering of [Mg2+]0 led to rapid activation of
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several isoforms of protein kinase C, P-I-3 kinases, mitogen-activated
kinases, tyrosine-activated kinases [45-51], and at least five major
enzymes in the sphingolipid biosynthetic pathway [52-61]. Prior to
these findings, we [41,52,62,63] and others [64,65] reported that a
variety of sphingolipid bi-products, namely ceramides, sphingosine,
sphingosine-phosphates, etc., can induce contraction of VSM cells in
the brain and elsewhere in the body. We have reported that inhibition
of the activation of the major synthetic pathways for ceramides in
cerebral VSM cells, using specific inhibitors for each enzyme, resulted in
marked attenuation of the contractions of cerebral blood vessels upon
the lowering of [Mg2+]0 concomitant with reductions in the cellular
rises of intracellular free Ca2+ [41,52,55-61, unpublished experiments].
Until very recently we believed that alcohol-induced cellular loss
of [Mg2+] coupled to cellular entry and release of Ca2+ with rapid
synthesis of ceramides might explain a great deal of alcohol-induced
cerebral vasoconstriction and brain ischemic events. However, we now
believe at least one more cellular compound, namely PAF and PAF-like
molecules, probably plays an important role in alcohol-induced brain
ischemic events, euphoria, and hallucinations.
Why focus on PAF? PAF and PAF-like molecules are known
to affect multiple physiologic aspects of neuronal and cardiac
functions [66-68]. For example, PAF can produce coronary arterial
vasoconstriction, lower arterial blood pressure, increase coronary
vascular resistance, release several lipid-like molecules from the heart,
reduce cardiac output, decrease cardiac contractility, alter atrial and
papillary muscle chronotropicity and membrane action potentials,
as well as alter potassium currents in isolated cardiomycytes [66-68].
All of these actions could lead one to believe that a rapid synthesis of
PAF and PAF-like substances might play fundamental roles in alcoholinduced ischemia, euphoria, and hallucinations set into motion by a
rapid lowering of [Mg2+]. As a first step in testing this hypothesis, we
determined whether a rapid reduction in [Mg2+]0 would result in the
synthesis and release of PAF. Using isolated cerebral VSM cells in primary
cell cultures, we recently reported that lowering [Mg2+]0, as predicted,
does indeed rapidly lead to the cellular synthesis and release of PAF and
PAF-like substances [69]. We and others have clearly demonstrated
that PAF and PAF-like substances induce vasoconstriction of cerebral
arterioles and venules in the intact brains of rodents using TV-image
-intensification microscopy [69]. Whether or not use of inhibitors of
PAF and ceramide synthesis coupled to increased dietary intake of
Mg will attenuate the euphoric and hallucinatory actions of ethanol
imbibed in cocktails, beers, etc., remains to be tested, but in our opinion
seems like a worthwhile undertaking.
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